Editorial: Antimicrobial resistance in pediatric infectious diseases: antimicrobial resistance, resistance mechanisms and antimicrobial use

Dingle Yu; Yuejie Zheng; Adong Shen; Fann Wu; Alexander V Dmitriev; Mogens Kilian; Yonghong Yang

doi:10.3389/fcimb.2023.1287051

Editorial: Antimicrobial resistance in pediatric infectious diseases: antimicrobial resistance, resistance mechanisms and antimicrobial use

Front Cell Infect Microbiol. 2023 Sep 26:13:1287051. doi: 10.3389/fcimb.2023.1287051. eCollection 2023.

Authors

Dingle Yu¹, Yuejie Zheng¹, Adong Shen², Fann Wu³, Alexander V Dmitriev⁴, Mogens Kilian⁵, Yonghong Yang⁶

Affiliations

¹ Department of Respiratory Medicine, Shenzhen Children's Hospital, Shenzhen, China.
² Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Laboratory of Respiratory Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
³ Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
⁴ Institute of Experimental Medicine, Academy of Medical Sciences, Saint Petersburg, Russia.
⁵ Bacterial Population Genetics, Copenhagen University, Copenhagen, Denmark.
⁶ Microbiology Laboratory, National Center for Children's Health, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.

No abstract available

Keywords: antimicrobial resistance; antimicrobial use; child; infectious disease; mechanism.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents* / pharmacology
Anti-Infective Agents* / therapeutic use
Child
Communicable Diseases* / drug therapy
Drug Resistance, Bacterial
Humans

Substances

Anti-Bacterial Agents
Anti-Infective Agents

Grants and funding

This work was supported by the Project of the Expert Committee on Clinical Application and Drug Resistance Evaluation of Antimicrobial Drugs of the National Health Commission of China(KJYWZWH-OT-02-2021-06), Guangdong High-level Hospital Construction Fund, and Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties(SZGSP012).